Alpha Centric Advisors LLC Roivant Sciences Ltd. Transaction History
Alpha Centric Advisors LLC
- $121 Million
- Q2 2024
A detailed history of Alpha Centric Advisors LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 88,000 shares of ROIV stock, worth $1.08 Million. This represents 0.77% of its overall portfolio holdings.
Number of Shares
88,000
Previous 90,000
2.22%
Holding current value
$1.08 Million
Previous $948,000
1.9%
% of portfolio
0.77%
Previous 0.66%
Shares
4 transactions
Others Institutions Holding ROIV
# of Institutions
308Shares Held
496MCall Options Held
989KPut Options Held
1.15M-
Sb Investment Advisers (Uk) LTD London, X071.4MShares$878 Million6.97% of portfolio
-
Viking Global Investors LP69.2MShares$851 Million2.91% of portfolio
-
Qvt Financial LP New York, NY66.7MShares$821 Million72.99% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$435 Million0.01% of portfolio
-
Morgan Stanley New York, NY29.3MShares$361 Million0.02% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.66B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...